Oncotherm

Oncotherm is a private oncology medical device company focused on oncothermia, its proprietary modulated electro-hyperthermia (mEHT) technology for supportive and complementary cancer treatment. The company develops, manufactures, and markets CE-marked loco-regional and multi-local hyperthermia systems intended to selectively deliver radiofrequency energy to malignant tissue. Its technology is positioned for use alongside standard modalities such as radiotherapy and chemotherapy, with commercial installations in multiple countries and a broad network of treatment centers. Oncotherm's product portfolio includes systems such as EHY-2000plus, EHY-2030, and EHY-3010 for solid tumor applications. The business appears to be centered on device commercialization, clinical support, and continued technical development rather than traditional drug discovery.